FDA Inspection 1269753 — Apotex Inc.
The FDA completed an inspection of Apotex Inc. on Jul 31, 2025 in North York. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North York (Canada)
Additional Details
Postmarket Adverse Drug Experience (PADE)